ʻO ka cenical carcinoma cracinoma patonalogy

ʻO ka cenical carcinoma cracinoma patonalogy E hoʻopuni ana i ka loiloi microscopic a me ka nānāʻana o nā kāhiko o ka conicnose i ka diagnose a aʻo i ke kanesal carney. He hana koʻikoʻi ia i ka hoʻoholoʻana i keʻano, pae, a me ke kahua o ke kanesa,ʻo nā hoʻoholo ponoʻana o ka mālamaʻana i nā hoʻoholoʻana a me nā hoʻolahaʻana o ka maʻi. ʻO ka hoʻomaopopoʻana i nā hiʻohiʻona pathological he mea nui no nā mea maʻi a me nā mea maʻi maʻi. Hāʻawi kēia alakaʻi i kahi kiko'ī kiko'ī o ʻO ka cenical carcinoma cracinoma patonalogy, me nā kulana maʻamau,ʻo nā pūnaehana maʻamau,ʻo ke kāʻeiʻana, ke kūʻana aku, a me ka hana o ka immunhinstoche.andorionRenal Center Carcinoma (RCC) ʻo ia kaʻano maʻamau o ka maʻi o ke keiki kāne i nā pākeke, he moʻokāki no ka 90% o nā mea waiwai a nā keiki kāne a pau. Kuʻikaʻikaʻikaʻi ia i ka leleʻana o ka tupled tibumal Ua hoʻolaʻaʻia, kahi liʻiliʻi nā'āpana liʻiliʻi i ke kō a me nā urine. ʻO ka maʻi maʻi kūpono a me ka heluʻana o RCC he paramulant no ke alakaʻiʻana i nā hoʻolālā palekana o RCCILLSE. Hiki ke hoʻololiʻia kēia mau subtypes ma lalo o ka loiloi microscopic a ua hōʻoia houʻia e immunohistochemistry. ʻO nā subtyps nui i kauʻia: E hoʻomaʻemaʻe i nā cell cell carcinoma (ccrcc) crall cell rccty ka countlet Hōʻikeʻia ia e nā cell me nā cyoplass a iʻole ka cyoplass ma muli o keʻano kiʻekiʻe o Glycogen a me Lipid. ʻO kēia mau'ōkuhi e hana pinepine ai i nā pale a iʻole nā ​​pepa, aʻo ka tumor ka mea maʻamauʻo VCCCularized RCC i ka lua Ua hōʻikeʻia e ka poʻe papa inoaʻo Papilary ʻElua mauʻano nui o ka PRCC:ʻano 1 a me keʻano 2.ʻO keʻano he prcChoder carcinoma (chccrophobe chocnod i kahi o ka carcinoma (chccromophobe reccnone ʻO nā cells o chrc i loaʻa i kahi cytoplasm eosinophilic o nā cytoplasm a me kahiʻano maʻamauʻo iaʻo Perinulear Halo. Hoʻokomo pinepineʻia nā nuclei a iʻole ka hoʻokaʻawaleʻana i ka carcinoma cracinoma denal carcinoma ʻO nā moʻokāki no ka liʻiliʻi ma mua o 1% o nā hihia RCC. ʻO ka Tumor Call i nā tubules i nā tubules a me ka papillae, pinepine me kahi maʻi carcinomis carcinoma. Hōʻikeʻia kēiaʻano likeʻole e ka carcinomaʻokoʻa maikaʻiʻole me kahi'ōnaehana carcinoma. Ua hoʻohanaʻia keʻano o ka'ōnaehana Furman Grownmball i hoʻohanaʻia, akāʻo ka honua honua honua o ka pākeke Urological (Isup) ʻO ka'ōnaehana GOCK GOGING SUDDERS NUCUNLANR PRANCELAR i ka kaulana a me keʻano nukle. Hōʻike nā helu kiʻekiʻe i nā mea nui e hōʻike hou aku ai i nā mea hoʻonāukiuki hou a pili pū me ka prosnosis porer. ʻO ka helu helu helu ISUP 1 liʻiliʻi, e hoʻohana i nā nuccai me ka inconspicuous a iʻole ka huhū. Helu 2 iʻoi aku ka nui o ka nuclei me nā nucleoli iʻikeʻia. ʻO ka helu 3 nui, nui, nuclei nui me nā nucleoli. ʻO ka papa helu 4 mau mea nui, pleomorphic nuclei me nā shapes a sarrore a iʻole sarcomuad likeʻole. Ke heleʻana o ka carcinoma carcinoma:ʻo ka'ōnaehana gencystaging o RCC e wehewehe ana i ka nui o ka maʻi maʻi (t) ʻO ka'ōnaehana TNM staging maʻamauʻo ia ka'ōnaehana maʻamau maʻamau no ka staging rcc. ʻO keʻano kūpono kūpono no ka hoʻoholoʻana i nā koho prognosis a me nā koho ponoʻana no ka nui o nā monia, a me nā kiko'ī o ka moni a me nā mea nānāʻole. Hoʻohana nā pathologists i nā hopena microscopic a me ka noʻonoʻoʻana i nā hualoaʻa e hāʻawi i ka TMM State.Munmunhitistochemistry (Ihc) he mea nui i loko ʻO ka cenical carcinoma cracinoma patonalogy. ^. Hoʻopili ia i ka hoʻohanaʻana i nā antibodies eʻike i nā protein kūikawā i loko o nā kiʻi kiʻi. ʻO kēiaʻenehana hana i nā'āpana likeʻole ma waena o RCC Subtypes, e hōʻoia ana i ka maʻi maʻi, a me ka hoʻomaopopoʻana i nā pahuhopu i hiki ke loaʻa i nā mea iʻikeʻia. Hoʻohanaʻia nā māka IHC maʻamau ma RCC e pili ana i RCC CAIX: pinepine pinepineʻia ma nā cracinoma cell cell renal carcinomas. CK7: kōkua i ka hoʻokaʻawaleʻana ma waena o nā subtyps likeʻole RCC ʻO ka maʻalahi: pinepine pinepine ma SarcatoID RCC. CD117 (C-K-Kit) E pili ana i nā mea e pili ana i kēia mau mea i kēia manawa:'ikeʻike a me nā kiko'ī kiko'ī. Ka wehewehe kiko'ī o ka tumor. ʻO ka ho'ākāka MicroscoPicic o nā cell tumor a me ka hoʻolālā. Rcc subype maʻi. Ka papa helu. Tnm papa. ʻO nā hualoaʻa emphunohistochehical. ʻO ke kūlana Margins (inā paha i loaʻa nā Cerels Crolls i nā kihi o ka neʻe i laweʻia). ʻO nā'ōlelo a Pathologist a me ka hōʻuluʻulu'ana.Thery.the Role o Shandong Badong Bador Cancer noiʻi noiʻi i keʻano o nā mea kōkua Canicer Shandong banufa cancer noiʻi noiʻi E pāʻani i kahi hana koʻikoʻi i ka hoʻomaikaʻiʻana i ko mākouʻike a me ka mālamaʻana i nā pale, e komo pū ana renal Center Carcinoma. ^. Ma ka hanaʻana i nā noiʻi a me nā hoʻokolohua lapaʻau e hāʻawi ana i kēia mau hui i ka hoʻomohalaʻana i nā mea hana diagnostic hou a me nā mea hana maikaʻi loa e hoʻomaikaʻi ana i nā mea hoʻomanawanuiʻO ka cenical carcinoma cracinoma patonalogy he kahua paʻakikī e pili ana i ka nānāʻana i ka nānāʻana a me ka nānāʻana o nā kāpena cubney. Hoʻomaopopo i nā subypes likeʻole, ke alohaʻana i nā'ōnaehana, stating, a me ka role o immuninoromismortle, a me ka hoʻolālā hoʻolālāʻana. ʻO ka huiʻana ma waena o nā poʻe Pathologists, nā Octologists, a me nāʻoihana olakino'ē aʻe no ka hāʻawiʻana i ka mālama maikaʻi loa no RCC.Hōʻike: ʻO kēiaʻikepili no kaʻike ākea a me kaʻikeʻike wale nō,ʻaʻole ia he'ōlelo aʻo olakino. He mea nui ke kamaʻilio me kahiʻoihana olakino kūpono no nā hopohopo olakino a iʻole ma mua o ka hanaʻana i nā hoʻoholo e pili ana i kou olakino a iʻole ka mālamaʻana.Nā Nūhou: ʻAmelikaʻAmelika Hui PūʻIa Nā kumuhana'ōliʻi